Nexien BioPharma, Inc. (NXEN)

OTCMKTS · Delayed Price · Currency is USD
0.0090
+0.0005 (5.56%)
Apr 23, 2025, 4:00 PM EDT
-44.79%
Market Cap 636.95K
Revenue (ttm) n/a
Net Income (ttm) -211.15K
Shares Out 70.77M
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,000
Average Volume 2,725
Open 0.0095
Previous Close 0.0090
Day's Range 0.0090 - 0.0095
52-Week Range 0.0040 - 0.0500
Beta 0.36
RSI 41.84
Earnings Date May 14, 2025

About Nexien BioPharma

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado. [Read more]

Sector Healthcare
CEO Richard Greenberg
Country United States
Stock Exchange OTCMKTS
Ticker Symbol NXEN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.